INDUSTRY × Prostatic Neoplasms × Other hematologic neoplasm × Clear all PERSIST
Enrolling by invitation
178 enrolled
CAMPERR
Recruiting
7,000 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Phase 1/2 Terminated
137 enrolled 31 charts
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
ROOT
Completed
167 enrolled
Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms
Phase 1/2 Recruiting
36 enrolled
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed
17,667 enrolled
GBCPRT0008
Withdrawn
RESTORE
Phase NA Unknown
352 enrolled
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.
Phase 1 Completed
118 enrolled
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
Phase 1 Completed
89 enrolled
PREDICARE
Completed
420 enrolled
A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer
Phase 1 Completed
128 enrolled
Safety Study of APR-246 in Patients With Refractory Hematologic Cancer or Prostate Cancer
Phase 1 Completed
36 enrolled
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Phase 1 Completed
25 enrolled
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Phase 1 Completed
25 enrolled
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Phase 3 Completed
130 enrolled 9 charts
A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)
Phase 1 Completed
113 enrolled
Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Phase 1 Unknown
45 enrolled